Physiotherapy and Rehabilitation in Melorheostosis: A Case Report (NCT07521150) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Physiotherapy and Rehabilitation in Melorheostosis: A Case Report
Turkey (Türkiye)1 participantsStarted 2026-04-18
Plain-language summary
The aim of this study is to evaluate the effects of a structured physiotherapy and rehabilitation-based exercise program on clinical and functional parameters in a patient diagnosed with melorheostosis.
This study specifically aims to assess the effects of a structured physiotherapy and rehabilitation-based intervention program, including patient education and therapeutic exercise, on lower extremity functional parameters, muscle strength, balance, and quality of life in a patient with melorheostosis.
The main hypotheses:
H0: A structured physiotherapy and rehabilitation-based exercise program has no effect on improvement in clinical and functional evaluation parameters in a patient with melorheostosis.
H1: A structured physiotherapy and rehabilitation-based exercise program leads to improvement in clinical and functional evaluation parameters in a patient with melorheostosis.
Who can participate
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with melorheostosis by a physician.
* Voluntarily agreeing to participate in the study and providing written informed consent.
* Being under physician follow-up for the disease.
* Being 18 years of age or older.
* Having the cognitive level, communication skills, and physical capacity to perform the planned exercise program.
Exclusion Criteria:
* Presence of additional systemic, rheumatologic, or metabolic diseases that could affect bone metabolism, other than melorheostosis.
* Presence of cardiovascular, pulmonary, or neurological disease at a level that may restrict exercising.
* History of surgical intervention or severe trauma within the last six months.
* Presence of psychiatric or cognitive disorders that could interfere with evaluation and exercise applications.
* Failure to continue the 8-week exercise program.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.